D
TScan Therapeutics, Inc. TCRX
$1.82 $0.084.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -8.28% 4.70% -19.81% 5.60% -5.04%
Total Depreciation and Amortization 2.95% -4.64% -30.77% -7.97% -11.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.75% -7.42% 98.77% -42.86% 23.53%
Change in Net Operating Assets 106.05% -221.39% 1,984.95% -112.78% 203.51%
Cash from Operations 11.49% -37.12% 1.81% -6.46% 10.39%
Capital Expenditure 16.51% -72.52% 35.18% -58.93% -22.27%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 230.08% -46.55% 134.80% -146.49% -189.11%
Cash from Investing 258.00% -50.43% 133.14% -144.25% -193.23%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -69.27% -96.31% 12,812.79%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 85.71% -101.75% -- -100.00% --
Cash from Financing 122.10% -101.15% 3,614.63% -99.24% 62,530.62%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 162.19% -153.94% 141.79% -207.28% 1,320.83%